For instance, to guide treatment decision, patients are routinely classified based on lymph node status, tumor size, and the positivity or negativity of the tumor for various receptors, such as hormonal receptors or human epidermal growth factor receptor 2 (HER2) (as reviewed by Cardoso et al. [9]). Here, ERBB2 is linked to neoplasm.